Disease
Featured
News Report
Technology
Insilico Medicine and University of Toronto Partner to Develop AI Drugs for ‘Undruggable’ Cancer Targets
February 1, 2024
News Report
Technology
Alphabet’s Isomorphic Labs Partners Lilly and Novartis for AI-driven Drug Discovery
January 8, 2024
News Report
Technology
Rikkeisoft Announces $10 Million Investment Plan for AI Healthcare Applications in Japan
December 18, 2023
News Report
Technology
AI Model ‘Ceograph’ Achieves Precision in Predicting Cancer Outcomes from Tissue Samples
December 12, 2023
Featured
News Report
Technology
Insilico Medicine Advances AI-Designed IBD Drug ISM5411 to ‘First-in-Human’ Trial
by Victor Dey
December 7, 2023
News Report
Technology
Healthtech Company Vinbrain Unveils Two AI-Powered Solutions to Bolster Patient Care
December 4, 2023
News Report
Technology
AstraZeneca Launches Health-Tech Division ‘Evinova’ to Speed Up Clinical Trials Using AI
November 20, 2023
News Report
Technology
Almirall and Absci Partner to Harness Generative AI for Drug Discovery
November 14, 2023
Hot Stories
Hong Kong’s HSC Asset Management Panel Points To Diversification, Liquidity Discipline And Risk-Managed Capital Allocation As Key Industry Trends
by Alisa Davidson
February 26, 2026
Galaxy S26 Highlights Samsung’s AI-First Strategy Amid Industry Push For Smart Device Intelligence
by Alisa Davidson
February 26, 2026
RealFi And What To Expect In 2026 From Major Players
by Alisa Davidson
February 26, 2026
Liquidity, Retail Access, and DeFi Integration Discussed As Catalysts For Tokenized Asset Growth At HSC Asset Management In Hong Kong
by Alisa Davidson
February 26, 2026
Latest News
DOGEBALL Crypto Presale 2026: Claim 75% Bonus as ETH Price Dips and HYPE Targets $38 Recovery
by Gregory Pudovsky
February 26, 2026
RealFi And What To Expect In 2026 From Major Players
by Alisa Davidson
February 26, 2026
Lista DAO Introduces Lista Credit To Redefine On-Chain Trading
by Alisa Davidson
February 26, 2026
Brazil’s 2027 Crypto Regulation Plan Signals New Era For Institutional Oversight
by Alisa Davidson
February 26, 2026